Wilson Sonsini Goodrich & Rosati advised Arcellx on the deal.Arcellx, a privately held clinical-stage biopharmaceutical company, announced that it raised $115 million in a Series C…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now